Acostream Use in Patients With High Risk and Intermediate-risk Acute Pulmonary Embolism

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 127 participants.

Also called NCT06946732

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 127 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT06946732
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT06946732. Allocation not applicable; no masking; primary purpose treatment. Start 2025-04-01 (actual); primary completion 2025-12-31 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Acostream Use in Patients With High Risk and Intermediate-risk Acute Pulmonary Embolism
Condition
Pulmonary Embolism (PE)
Intervention (Device)
Acostream aspiration
Lead sponsor
RenJi Hospital (class: other)
Collaborator
Xiamen Cardiovascular Hospital, Xiamen University (class: other)
Collaborator
Nantong University Affiliated Hospital (class: not stated)
Collaborator
Chengdu University of Traditional Chinese Medicine (class: other)
Collaborator
Shanghai No.1 Hospital (class: not stated)
Collaborator
First Affiliated Hospital of Fujian Medical University (class: other)
Collaborator
Jinhua Central Hospital (class: other)

Record details

Record id
cardio:ct-nct06946732
Content hash
2559156c66c6a71eda000a7c790249a689b89f8d15413a150f1bfdbcd3a1e445